Takeda Pharmaceutical Company （TAK） 2017年可持续发展价值报告「NYSE」.pdf

1、Creating value for patients around the worldSustainable Value Report 2017Takeda Sustainable Value Report 2017Message from the President&CEOTakedas Business ModelTakedas MaterialityAction Mapping for SDGsAccess to HealthcareSupplier ManagementTakedas CSR ActivitiesBasic Policy on CSRCSR Governance an

2、d Strategic EngagementResponsible BusinessCorporate GovernanceComplianceRisk&Crisis ManagementTakeda ManagementQuality Management SystemHuman RightsAt a GlanceHuman Rights Issues and InitiativesLaborAt a GlanceGlobal Talent ManagementDiversity&InclusionOccupational Health and SafetyEnvironmentAt a G

3、lanceEnvironmental ManagementReducing EHS RisksInitiatives to Deal with Climate ChangeWater Resources Conservation InitiativesBiodiversity Conservation InitiativesWaste ReductionReduction in Releases of Chemical SubstancesAir,Water,and Soil Quality ConservationActivities at SitesEnvironmental Impact

4、s Associated with Takedas Business ActivitiesData by RegionAnti-CorruptionAt a GlanceAnti-CorruptionTransparency GuidelineCorporate Citizenship ActivitiesAt a GlanceGlobal Healthcare IssuesHealthcare Issues in Each Business AreaSupport for Disaster-Affected Areas1246814182022242526283234363840414244

5、48495253545556575860626364666869Corporate Information and Fiscal 2016 Results Takedas Growth DriversUnited Nations Global Compact Advanced Level COP Reference TableGRI Standards Reference TableIndependent Assurance of Environmental and Social Performance Indicators7071727682Reporting BoundaryConsoli

6、dated subsidiaries of Takeda*In some places,we present non-consolidated data for Takeda Pharmaceutical Company Limited.Period of ReportingFiscal 2016(April 1,2016 to March 31,2017)*Some fiscal 2017 activities are included.Issue DateOctober 2017Reference Guidelines The International Integrated Report